Apyx Medical Corp — Director's Dealing 2020

Mar 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Apyx Medical Corp (APYX)
CIK: 0000719135
Period of Report: 2019-04-04

Reporting Person: Swandal Craig A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-04	Common Stock	X	2000	$2.37	Acquired	20000	Direct
2019-04-04	Common Stock	O	6000	$5.30	Acquired	26000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-04	Stock Option (Option to Buy)	$2.37	X	2000	Disposed	2028-03-09	Common Stock (2000.0)	Direct
2019-04-04	Stock Option (Option to Buy)	$5.3	O	6000	Disposed	2028-08-29	Common Stock (6000.0)	Direct

Footnotes

F1: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.